U.S. Office-based Labs Market Size

U.S. Office-based Labs Market Size

U.S. Office-Based Labs Market size was valued at USD 11.2 billion in 2023 and is estimated to grow at a CAGR of 7.6% during the forecast period to reach USD 21 billion by 2032. An office-based labs (OBLs) refers to a medical facility located within a physician’s office or clinic that is equipped to perform diagnostic and therapeutic procedures on-site.

To get key market trends

  Download Free Sample

These labs are designed to provide convenient access to medical services for patients while allowing physicians to maintain greater control over the diagnostic process and treatment plans. The increasing prevalence of target diseases, such as chronic kidney disease, deep vein thrombosis, and venous insufficiency, has emerged as a significant driver for the market. For instance, according to the Centers for Disease Control and Prevention (CDC), approximately 35.5 million adults were affected by chronic kidney disease (CKD) in the U.S.

Furthermore, growing advancements in medical technology have expanded the capabilities of performing a diverse array of diagnostic tests and treatments within office-based settings. The increasing adoption of endovascular treatment devices for various procedures, coupled with other contributing factors.